ArticlePloS one2025
Nuclei segmentation and classification from histopathology images using federated learning for end-edge platform.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Federated Learning for Histopathology Image Classification: A Systematic Review.Diagnostics (Basel, Switzerland) · 2026Review
- Correction: Nuclei Segmentation and Classification from Histopathology Images using Federated Learning for End-Edge Platform.PloS one · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate nuclei segmentation and classification in histology images are critical for cancer detection but remain challenging due to color inconsistency, blurry boundaries, and overlapping nuclei. Manual segmentation is time-consuming and labor-intensive, highlighting the need for efficient and scalable automated solutions. This study proposes a deep learning framework that combines segmentation and classification to enhance nuclei evaluation in histopathology images. The framework follows a two-stage approach: first, a SegNet model segments the nuclei regions, and then a DenseNet121 model classifies the segmented instances. Hyperparameter optimization using the Hyperband method enhances the performance of both models. To protect data privacy, the framework employs a FedAvg-based federated learning scheme, enabling decentralized training without exposing sensitive data. For efficient deployment on edge devices, full integer quantization is applied to reduce computational overhead while maintaining accuracy. Experimental results show that the SegNet model achieves 91.4% Mean Pixel Accuracy (MPA), 63% Mean Intersection over Union (MIoU), and 90.6% Frequency-Weighted IoU (FWIoU). The DenseNet121 classifier achieves 83% accuracy and a 67% Matthews Correlation Coefficient (MCC), surpassing state-of-the-art models. Post-quantization, both models exhibit performance gains of 1.3% and 1.0%, respectively. The proposed framework demonstrates high accuracy and efficiency, highlighting its potential for real-world clinical deployment in cancer diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.